SE7712430L - Antibiotikum a 10 - Google Patents
Antibiotikum a 10Info
- Publication number
- SE7712430L SE7712430L SE7712430A SE7712430A SE7712430L SE 7712430 L SE7712430 L SE 7712430L SE 7712430 A SE7712430 A SE 7712430A SE 7712430 A SE7712430 A SE 7712430A SE 7712430 L SE7712430 L SE 7712430L
- Authority
- SE
- Sweden
- Prior art keywords
- gram
- antibiotic
- novel
- lactamases
- feedstuffs
- Prior art date
Links
- 239000003242 anti bacterial agent Substances 0.000 title 1
- 229940088710 antibiotic agent Drugs 0.000 title 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 abstract 2
- 230000003115 biocidal effect Effects 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 241000894006 Bacteria Species 0.000 abstract 1
- 108020004256 Beta-lactamase Proteins 0.000 abstract 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 abstract 1
- 241000958211 Streptomyces flavogriseus Species 0.000 abstract 1
- 239000000654 additive Substances 0.000 abstract 1
- 230000000996 additive effect Effects 0.000 abstract 1
- 230000001580 bacterial effect Effects 0.000 abstract 1
- 102000006635 beta-lactamase Human genes 0.000 abstract 1
- 229910052799 carbon Inorganic materials 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000000645 desinfectant Substances 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 238000002955 isolation Methods 0.000 abstract 1
- 229910052757 nitrogen Inorganic materials 0.000 abstract 1
- 235000015097 nutrients Nutrition 0.000 abstract 1
- 230000003389 potentiating effect Effects 0.000 abstract 1
- 238000004321 preservation Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
- C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
- C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
- C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
- C07D477/20—Sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
- C12P17/182—Heterocyclic compounds containing nitrogen atoms as the only ring heteroatoms in the condensed system
- C12P17/184—Heterocyclic compounds containing nitrogen atoms as the only ring heteroatoms in the condensed system containing a beta-lactam ring, e.g. thienamycin
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Communicable Diseases (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US74295876A | 1976-11-17 | 1976-11-17 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| SE7712430L true SE7712430L (sv) | 1978-05-18 |
| SE433621B SE433621B (sv) | 1984-06-04 |
Family
ID=24986929
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE7712430A SE433621B (sv) | 1976-11-17 | 1977-11-03 | Sett att framstella antibiotikum 890 a?7110 genom odling av streptomyces flavogriseus |
Country Status (10)
| Country | Link |
|---|---|
| JP (1) | JPS5363397A (sv) |
| CH (1) | CH634104A5 (sv) |
| DE (1) | DE2751303A1 (sv) |
| DK (1) | DK487977A (sv) |
| ES (1) | ES463973A1 (sv) |
| FR (1) | FR2371448A1 (sv) |
| GB (1) | GB1595233A (sv) |
| NL (1) | NL7712092A (sv) |
| PT (1) | PT67268B (sv) |
| SE (1) | SE433621B (sv) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ190994A (en) | 1978-07-24 | 1981-10-19 | Merck & Co Inc | Z-2-acylamino-3-monosubstituted propenoates |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1483142A (en) * | 1975-03-15 | 1977-08-17 | Beecham Group Ltd | Streptomycetal antibiotic |
| CH633554A5 (en) * | 1975-11-21 | 1982-12-15 | Merck & Co Inc | Process for the preparation of novel thienamycin derivatives. |
-
1977
- 1977-11-02 DK DK487977A patent/DK487977A/da unknown
- 1977-11-02 NL NL7712092A patent/NL7712092A/xx not_active Application Discontinuation
- 1977-11-03 SE SE7712430A patent/SE433621B/sv not_active IP Right Cessation
- 1977-11-08 ES ES463973A patent/ES463973A1/es not_active Expired
- 1977-11-11 PT PT67268A patent/PT67268B/pt unknown
- 1977-11-14 GB GB47324/77A patent/GB1595233A/en not_active Expired
- 1977-11-16 DE DE19772751303 patent/DE2751303A1/de not_active Ceased
- 1977-11-16 CH CH1401477A patent/CH634104A5/de not_active IP Right Cessation
- 1977-11-16 FR FR7734457A patent/FR2371448A1/fr active Granted
- 1977-11-17 JP JP13735677A patent/JPS5363397A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| DE2751303A1 (de) | 1978-05-18 |
| PT67268A (en) | 1977-12-01 |
| FR2371448A1 (fr) | 1978-06-16 |
| ES463973A1 (es) | 1978-11-16 |
| FR2371448B1 (sv) | 1980-03-14 |
| DK487977A (da) | 1978-05-18 |
| JPS5363397A (en) | 1978-06-06 |
| SE433621B (sv) | 1984-06-04 |
| NL7712092A (nl) | 1978-05-19 |
| PT67268B (en) | 1979-10-08 |
| JPS6310998B2 (sv) | 1988-03-10 |
| GB1595233A (en) | 1981-08-12 |
| CH634104A5 (en) | 1983-01-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY102919A (en) | Pleuromutilin derivatives process for their preparation and their use. | |
| SE7704301L (sv) | Antibiotika | |
| EP0196628A3 (en) | Ansamycin antibioticum, microbiological process for its preparation and its use as a medicament | |
| SE7712429L (sv) | Antibiotikum 890 a9 | |
| DE3880845D1 (de) | Durch fermentation hergestellte antibiotika. | |
| ES445913A1 (es) | Un procedimiento para la preparacion de una sal dibasica farmaceuticamente aceptable de m. m. 17880. | |
| ES463973A1 (es) | Un procedimiento para la preparacion del antibiotico 890a10. | |
| ES8308360A1 (es) | Un procedimiento para la produccion de un nuevo antibiotico. | |
| SE7612293L (sv) | Antibiotikum | |
| GB1500965A (en) | Cyclic ether antibiotics | |
| SE7707552L (sv) | Antibiotikum bl580delta | |
| ES8402286A1 (es) | Procedimiento para la obtencion de antibiotico de p-lactama. | |
| SE7612294L (sv) | Antibiotikum | |
| SE7705855L (sv) | Forfarande for framstellning av ett nytt antibiotikum kallat a-35512 | |
| AU584946B2 (en) | Organic chemical compound, microbiological processes for its preparation, and its use | |
| IE41378L (en) | Polycyclic ether antibiotic. | |
| FR2401162A1 (fr) | Antibiotique derive d'un streptomyces, utilisable comme medicament | |
| SE7708939L (sv) | Antibiotika | |
| ES466645A1 (es) | Un procedimiento para la produccion de desacetildihidro 890a9 | |
| IL70952A (en) | 19-epi-dianemycin and salts thereof,their preparation,pharmaceutical compositions and nutrient feed containing them | |
| SE8303727L (sv) | Cefalosporinantibiotika | |
| GB1388460A (en) | N-demethyl-celesticetin derivatives | |
| KR850006873A (ko) | 산성 폴리사이클릭 에테르 항생물질의 제조방법 | |
| JPS562980A (en) | Novel antibiotic substance a73a and its preparation | |
| SE7506509L (sv) | Forfarande for framstellning av ett nytt antibiotikum kallat a-28086. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| NUG | Patent has lapsed |
Ref document number: 7712430-3 Effective date: 19900706 Format of ref document f/p: F |